AstraZeneca's David Brennan - CEO Pay

David Brennan - AstraZeneca
Total Compensation: $4.3M
2007 Revenue: $29.55B
2006 Revenue: $26.47B
Change: 11.6%
Details: Brennan made 2.15 million pounds ($4.3 million) in 2007, about $2 million of that as base salary and the rest variable compensation. Though his base was set at 5.5 percent higher in 2007 than 2006, his total package dropped by 19 percent because of smaller bonus and decreased reimbursements for relocation expenses. Overall, his pay fell 19%.
AstraZeneca News:
AstraZeneca's CEO sees 19% pay cut
Analyst: AZ "worst performer" in pharma
AstraZeneca lays out road map for recovery
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: